Research ExplorerScientific StaffSusanna Carolina Berger

Dr.med. ID: 6360130

Susanna Carolina Berger

Group leader

graph of relations
Affiliations
Emails
Phone: 0049-40-7410-55917
ORCID: 0000-0001-9403-5957

Publications

CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis

Research output: SCORING: Contribution to journal › Case report › Research › peer-review

Impact of high-risk disease on the efficacy of chimeric antigen receptor T-cell therapy for multiple myeloma: a meta-analysis of 723 patients

Research output: SCORING: Contribution to journal › Letter › Research › peer-review

Clinical Implications and Dynamics of Clonal Hematopoiesis in Anti-CD19 CAR T-cell Treated Patients

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Donor Lymphocyte Infusion and Molecular Monitoring for Relapsed Myelofibrosis After Hematopoietic Cell Transplantation

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Molecular monitoring of T-cell kinetics and migration in severe neurotoxicity after real-world CD19-specific chimeric antigen receptor-T cell therapy

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Comparison of single copy gene‑based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19‑directed CAR T cells in treated patients

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Immune Monitoring

Research output: SCORING: Contribution to book/anthology › Chapter › Research

CAR-HEMATOTOX: A model for CAR T-cell related hematological toxicity in relapsed/refractory large B-cell lymphoma

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Axicabtagene ciloleucel in vivo expansion and treatment outcome in aggressive B-cell lymphoma in a real-world setting

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Immunogenic chemotherapy enhances recruitment of CAR-T cells to lung tumors and improves antitumor efficacy when combined with checkpoint blockade

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

View all (53)

activities

EBMT 46th Annual Meeting

Activity: Participating in or organising an event › Participation in conferences › Research

EHA-EBMT 3rd European CAR T-Cell Meeting

Activity: Participating in or organising an event › Participation in conferences › Research

2nd European CAR T Cell Meeting

Activity: Participating in or organising an event › Participation in conferences › Research

View all (3)